HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Loss of PTPRJ/DEP-1 enhances NF2/Merlin-dependent meningioma development.

AbstractINTRODUCTION:
Meningiomas are common tumors in adults, which develop from the meningeal coverings of the brain and spinal cord. Loss-of-function mutations or deletion of the NF2 gene, resulting in loss of the encoded Merlin protein, lead to Neurofibromatosis type 2 (NF2), but also cause the formation of sporadic meningiomas. It was shown that inactivation of Nf2 in mice caused meningioma formation. Another meningioma tumor-suppressor candidate is the receptor-like density-enhanced phosphatase-1 (DEP-1), encoded by PTPRJ. Loss of DEP-1 enhances meningioma cell motility in vitro and invasive growth in an orthotopic xenograft model. Ptprj-deficient mice develop normally and do not show spontaneous tumorigenesis. Another genetic lesion may be required to interact with DEP-1 loss in meningioma genesis.
METHODS:
In the present study we investigated in vitro and in vivo whether the losses of DEP-1 and Merlin/NF2 may have a combined effect.
RESULTS:
Human meningioma cells deficient for DEP-1, Merlin/NF2 or both showed no statistically significant changes in cell proliferation, while DEP-1 or DEP1/NF2 deficiency led to moderately increased colony size in clonogenicity assays. In addition, the loss of any of the two genes was sufficient to induce a significant reduction of cell size (p < .05) and profound morphological changes. Most important, in Ptprj knockout mice Cre/lox mediated meningeal Nf2 knockout elicited a four-fold increased rate of meningioma formation within one year compared with mice with Ptprj wild type alleles (25% vs 6% tumor incidence).
CONCLUSIONS:
Our data suggest that loss of DEP-1 and Merlin/NF2 synergize during meningioma genesis.
AuthorsNatalie Waldt, David Scharnetzki, Christoph Kesseler, Elmar Kirches, Nele Stroscher, Frank-D Böhmer, Christian Mawrin
JournalJournal of the neurological sciences (J Neurol Sci) Vol. 408 Pg. 116553 (Jan 15 2020) ISSN: 1878-5883 [Electronic] Netherlands
PMID31715329 (Publication Type: Journal Article)
CopyrightCopyright © 2019 Elsevier B.V. All rights reserved.
Chemical References
  • NF2 protein, human
  • Neurofibromin 2
  • PTPRJ protein, human
  • Receptor-Like Protein Tyrosine Phosphatases, Class 3
Topics
  • Animals
  • Animals, Newborn
  • Cell Line, Tumor
  • Humans
  • Meningeal Neoplasms (genetics, metabolism, pathology)
  • Meningioma (genetics, metabolism, pathology)
  • Mice
  • Mice, Transgenic
  • Neurofibromin 2 (deficiency, genetics)
  • Receptor-Like Protein Tyrosine Phosphatases, Class 3 (deficiency, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: